People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, ...

Experts highlight interventions to support muscle and nutrient preservation during GLP-1 treatment and offer practical ...

Researchers analyzed 11 different studies to understand weight outcomes after stopping anti-obesity medications called ...

The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.

GLP-1 drugs may reduce asthma symptoms in obese adults, offering a steroid-free alternative to treatment. The study includes ...

A Big Chalk Analytics survey of 4,511 U.S. shoppers in spring of 2025 showed that 11.2% of adults are using GLP-1 drugs, and ...

The demand for GLP-1 medications is only increasing. As employees seek better health benefits, employers who act now will set ...

Longer treatment duration, not having diabetes, and using semaglutide are among the factors linked to better weight reduction over 12 months.

A retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and ...

Pediatric endocrinologist Dr. Casey Berman says GLP-1s may help children reduce their risk of developing serious health ...

More and more research indicates that GLP-1 analogues can have a blunting effect on addictions like drugs and alcohol. Drug ...